BCL2 and neoplasm: Treatment with CisPt significantly reduced BCL-2 gene expression in FaDu (p < 0.05, *) and PE/CA-PJ49 (p < 0.025, *) tumor cell lines compared to the effect induced on the HaCaT normal line (Figure 2C, Table 3).